BioScience Health Innovations BHIC
OTC BHIC
$4.01 -0.99 (-19.80%)
At close: Aug 20, 2026 · 4:00 PM EDT

BioScience Health Innovations (BHIC) Non-Current Debt (2020 - 2021)

BioScience Health Innovations (BHIC) posted quarterly Non-Current Debt of $8713.0 for Q4 2021, little changed quarter-over-quarter from $8713.0 in Q3 2021.

BioScience Health Innovations (BHIC) Non-Current Debt (2020 - 2021) Analysis & Trends

BioScience Health Innovations (BHIC) has reported Non-Current Debt for 2 consecutive years, with $8713.0 the latest figure, recorded in Q4 2021.

  • In Q4 2021, Non-Current Debt changed N/A year-over-year to $8713.0; the TTM figure through Nov 2021 stood at $8713.0 (changed N/A YoY), while the FY2021 annual figure was $8713.0, up 1046.45% from the prior year.
  • Non-Current Debt was little changed at $8713.0 in Q4 2021 per BHIC's latest filing, from $8713.0 in the prior quarter.
  • Across five years, Non-Current Debt topped out at $8713.0 in Q3 2021 and bottomed at $760.0 in Q3 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 High Tide 214.40 Mn 181.12 Mn 35.30 Mn 8.63 Mn
2 BioScience Health Innovations 58.76 Mn 58.05 Mn 659,483.00 -
3 Petmed Express 38.16 Mn 25.06 Mn 11.33 Mn -
4 Scienture Holdings 18.24 Mn 18.24 Mn 335,779.00 9.57 Mn
5 Polomar Health Services 8.48 Mn 8.31 Mn 935,916.00 -
6 Ridgetech 58,577.68 -17.85 Mn - -

Historic Data

Download Data
DateValue
Nov 30, 2021 8,713.00
Aug 31, 2021 8,713.00
Aug 31, 2020 760.00